BioSpace News Archive

Innovative biotechnology company specializing in new drug discovery and development, Avelos Therapeutics, has received a glowing endorsement from the venture capital community by raising $8 million.

Imagin Medical Announces Acquisition of the enCAGE Coil™ Precision Ablation System for Prostate Cancer and a New $7.25M Convertible Note to Finance Its Development.

Becton, Dickinson and Company (NYSE: BDX) (the " Company " or " BD ") today announced the early tender results for its previously announced Tender Offers (as defined below) to purchase for cash certain of its outstanding debt securities listed in the table below.

Turn Biotechnologies announced that Albert Wu, MD, PhD, will oversee its development of ophthalmic therapeutic products as an advisor to the company.

ZyVersa Therapeutics, Inc. (“ZyVersa”), and Larkspur Health Acquisition Corp. (NASDAQ: LSPR or “Larkspur”), are pleased to announce that data published in Frontiers in Molecular Neuroscience demonstrate that ZyVersa’s inflammasome ASC inhibitor, IC 100, is effective in reducing inflammation in the brains of aged mice.

Precigen, Inc. today announced that the Company has completed the sale of its wholly-owned non-healthcare subsidiary, Trans Ova Genetics, L.C.

Thermo Fisher Scientific Inc., the world leader in serving science, opened its largest single-use technology manufacturing site in Greater Nashville.

MAIA Biotechnology, Inc. today reported financial results for the second quarter ended June 30, 2022, and provided a corporate update.

Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar” or the “Company”) today provided Company updates and reported consolidated second-quarter 2022 financial results.

Ophelia, digital provider of medication-assisted treatment (MAT) for opioid use disorder (OUD), today announced the expansion of both its executive team and technological capabilities with the appointment of Chief Technology Officer (CTO), Lon Binder.